X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf
https://www.globenewswire.com/news-release/2023/04/24/2652743/0/en/Assertio-Provides-Educational-Grant-for-New-Lennox-Gastaut-Syndrome-LGS-Foundation-Treatments-Kits.html
https://www.fiercepharma.com/pharma/aquestive-offloads-film-formulation-seizure-drug-assertio-securing-cash-epinephrine-rd
https://www.globenewswire.com/news-release/2022/10/27/2542933/0/en/Aquestive-Therapeutics-Licenses-Sympazan-clobazam-Oral-Film-to-Assertio-Holdings-Inc.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216008
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214404
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-26-2022-1643358623.pdf
http://www.pharmabiz.com/NewsDetails.aspx?aid=140113&sid=1#:~:text=%2B%20Font%20Resize%20%2D-,IPC%20sounds%20safety%20alerts%20against,Baclofen%2C%20combination%20of%20Rosuvastatin%2C%20Ticagrelor&text=As%20per%20drug%20safety%20alert,up%20to%2010%20per%20cent.
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213039
https://endpts.com/slammed-by-fda-rejection-aquestive-vows-to-refile-by-end-of-year/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209853
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211032
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212092
https://endpts.com/gw-pharmas-cannabis-derived-epilepsy-medicine-makes-the-cut-in-the-european-union/
http://www.pmlive.com/pharma_news/early_no_for_gw_pharmas_epilepsy_drug,_but_nice_vows_to_collaborate_1298991
http://www.pmlive.com/pharma_news/lundbecks_key_products_shine_in_q2_but_problems_remain_1297435
https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=6312019105346
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210746
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-seizure-drug-in-us/articleshow/69265256.cms
https://health.economictimes.indiatimes.com/news/pharma/lupin-launches-seizures-drug-in-us/68010401
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211711
https://www.biospectrumasia.com/news/34/12413/lupin-gets-fda-approval-for-clobazam-oral-suspension.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210545
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210545
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208785
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208819
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208825
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209308
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209440
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209687
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209715
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209718
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209795
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209808
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210039
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210569
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211259
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211449
https://www.prnewswire.com/news-releases/aquestive-therapeutics-announces-tentative-fda-approval-for-sympazan-clobazam-oral-film-300705498.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209687
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209718
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208825
https://www.prnewswire.com/news-releases/aquestive-therapeutics-announces-us-fda-filing-acceptance-of-new-drug-application-for-clobazam-oral-soluble-film-to-treat-lennox-gastaut-syndrome-300584383.html
http://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/mhra-advises-health-professionals-on-supply-of-clobazam-for-epilepsy/20203409.article
http://www.prnewswire.com/news-releases/clobazam-oral-suspension-approved-in-seven-european-countries-598158741.html
Market Place
Share 
